Chatbots mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say Promising design Using the same platform Moderna used for its mRNA COVID-19 vaccine, intismeran delivers to healthy cells the mRNA…
Chatbots OpenAI raises $122 billion to accelerate the next phase of AI Today, we closed our latest funding round with $122 billion in committed capital at a post money valuation of $852…
